| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Molecular Genetics and Immunobiology of Mycobacteria |
AgResearch, Wallaceville Animal Research Centre, PO Box 40063, Upper Hutt, New Zealand1
Author for correspondence: D. M. Collins. Tel: +64 4 922 1310. Fax: +64 4 922 1380. e-mail: desmond.collins{at}agresearch.co.nz
A better tuberculosis vaccine is urgently required to control the continuing epidemic. Molecular techniques are now available to produce a better live vaccine than BCG by producing avirulent strains of the Mycobacterium tuberculosis complex with known gene deletions. In this study, 1000 illegitimate recombinants of Mycobacterium bovis were produced by illegitimate recombination with fragments of mycobacterial DNA containing a kanamycin resistance gene. Eight recombinant strains were selected on the basis of their inability to grow when stationary-phase cultures were inoculated into minimal medium. Five of these recombinants were found to be avirulent when inoculated into guinea pigs. Two of the avirulent recombinants produced vaccine efficacy comparable to BCG against an aerosol challenge in guinea pigs with M. bovis. One of these recombinants had an inactivated glnA2 gene encoding a putative glutamine synthetase. Transcriptional analysis showed that inactivation of glnA2 did not affect expression of the downstream glnE gene. The other recombinant had a block of 12 genes deleted, including the sigma factor gene sigG. Two avirulent recombinants with an inactivated pckA gene, encoding phosphoenolpyruvate carboxykinase which catalyses the first step of gluconeogenesis, induced poor protection against tuberculosis. It is clear that live avirulent strains of the M. tuberculosis complex vary widely in their ability as vaccines to protect against tuberculosis. Improved models may be required to more clearly determine the difference in protective effect between BCG and potential new tuberculosis vaccines.
Keywords: tuberculosis, Mycobacterium tuberculosis, vaccines, virulence, BCG, guinea pig
Abbreviations: PPD, purified protein derivative
This article has been cited by other articles:
|
|
 |
|
  P. Carroll, C. A. Pashley, and T. Parish Functional Analysis of GlnE, an Essential Adenylyl Transferase in Mycobacterium tuberculosis J. Bacteriol., July 15, 2008; 190(14): 4894 - 4902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Pashley, A. C. Brown, D. Robertson, and T. Parish Identification of the Mycobacterium tuberculosis GlnE promoter and its response to nitrogen availability. Microbiology, September 1, 2006; 152(Pt 9): 2727 - 2734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-J. Tang, Y.-Q. He, J.-X. Feng, B.-R. He, B.-L. Jiang, G.-T. Lu, B. Chen, and J.-L. Tang Xanthomonas campestris pv. campestris Possesses a Single Gluconeogenic Pathway That Is Required for Virulence J. Bacteriol., September 1, 2005; 187(17): 6231 - 6237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Collins, B. Skou, S. White, S. Bassett, L. Collins, R. For, K. Hurr, G. Hotter, and G. W. de Lisle Generation of Attenuated Mycobacterium bovis Strains by Signature-Tagged Mutagenesis for Discovery of Novel Vaccine Candidates Infect. Immun., April 1, 2005; 73(4): 2379 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Hotter, B. J. Wards, P. Mouat, G. S. Besra, J. Gomes, M. Singh, S. Bassett, P. Kawakami, P. R. Wheeler, G. W. de Lisle, et al. Transposon Mutagenesis of Mb0100 at the ppe1-nrp Locus in Mycobacterium bovis Disrupts Phthiocerol Dimycocerosate (PDIM) and Glycosylphenol-PDIM Biosynthesis, Producing an Avirulent Strain with Vaccine Properties At Least Equal to Those of M. bovis BCG J. Bacteriol., April 1, 2005; 187(7): 2267 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Karakousis, T. Yoshimatsu, G. Lamichhane, S. C. Woolwine, E. L. Nuermberger, J. Grosset, and W. R. Bishai Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice J. Exp. Med., September 7, 2004; 200(5): 647 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mehta, J. T. Pearson, S. Mahajan, A. Nath, M. J. Hickey, D. R. Sherman, and W. M. Atkins Adenylylation and Catalytic Properties of Mycobacterium tuberculosis Glutamine Synthetase Expressed in Escherichia coli versus Mycobacteria J. Biol. Chem., May 21, 2004; 279(21): 22477 - 22482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Timm, F. A. Post, L.-G. Bekker, G. B. Walther, H. C. Wainwright, R. Manganelli, W.-T. Chan, L. Tsenova, B. Gold, I. Smith, et al. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients PNAS, November 25, 2003; 100(24): 14321 - 14326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Collins, R. P. Kawakami, B. M. Buddle, B. J. Wards, and G. W. de Lisle Different susceptibility of two animal species infected with isogenic mutants of Mycobacterium bovis identifies phoT as having roles in tuberculosis virulence and phosphate transport Microbiology, November 1, 2003; 149(11): 3203 - 3212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Liu, J. Yu, and D. G. Russell pckA-deficient Mycobacterium bovis BCG shows attenuated virulence in mice and in macrophages Microbiology, July 1, 2003; 149(7): 1829 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Young Mycobacteria research in the post-genomic era Microbiology, October 1, 2002; 148(10): 2915 - 2917. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
